ZEPP HEALTH CORP Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Sales
ZEPP HEALTH CORP (ZEPP) reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Sales of -$8.50 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-24.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSales · last filed 2026-04-24
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Sales 12 month |
|---|---|
| 2025-12-31 | -$8.50M 20-F · filed 2026-04-24 |
| 2024-12-31 | -$275.00K 20-F · filed 2026-04-24 |
| 2023-12-31 | -$1.26M 20-F · filed 2025-04-25 |